Fucosylation in Urological Cancers

Area of Science:

• Glycobiology
• Cancer Biology
• Immunology

Background:

• Fucosylation is a critical oligosaccharide modification influencing immune responses and cancer progression.
• Specific fucosyltransferases (FUTs) catalyze distinct fucosylation types, impacting cancer cell proliferation, invasiveness, and chemotherapy resistance by altering signaling receptor glycosylation.

Purpose of the Study:

• To explore the role of fucosylation in urological malignancies.
• To investigate fucosyltransferases (FUTs) as potential biomarkers and therapeutic targets in cancers such as renal cell carcinoma, bladder cancer, and prostate cancer.

Main Methods:

• Analysis of fucosylation patterns in cancer cells.
• Investigation of fucosyltransferase (FUT) expression levels in urological tumors.
• Exploration of aberrant fucosylation in biomarkers like prostate-specific antigen (PSA).

Main Results:

• Fucosyltransferases (FUTs) are upregulated in renal cell carcinoma, bladder cancer, and prostate cancer.
• Aberrant fucosylation of prostate-specific antigen (PSA) shows potential as a novel prostate cancer biomarker.
• Fucosylation of PD-1/PD-L1 proteins leads to functional modifications relevant to cancer immunity.

Conclusions:

• Fucosylation plays a significant role in the development and progression of urological malignancies.
• Targeting fucosylation pathways and utilizing fucosylation-based biomarkers offer promising avenues for cancer therapy and diagnosis.
• Further research into fucosylation glycobiology is essential for advancing treatment strategies in urological cancers.